Nafise Ghalandari (N Ghalandari)

Years Active: 2020-2023
Publications (10 Years): 5

Erasmus MC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus MC Jun 01 2017

Netherlands

PhD student :: Rheumatology

Publications

Nafise Ghalandari, Maarten M Immink, Esther Röder, Patricia C J Bruijning-Verhagen, Hieronymus T W Smeele, Hubertina Crijns, Nicoline A T van der Maas, Mireille N Bekker, Elisabeth A M Sanders, Radboud J E M Dolhain
Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic disease. RMD open 9 (3) (2023)
Nafise Ghalandari, Hubertina Jmj Crijns, Radboud Jem Dolhain, Johanna Mw Hazes, Eugene P van Puijenbroek
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance. Lupus (2022)
Nafise Ghalandari, Hubertina J M J Crijns, Jorieke E H Bergman, Radboud J E M Dolhain, Eugène P van Puijenbroek, Johanna M W Hazes
Reported congenital malformations after exposure to non-tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance. British journal of clinical pharmacology 88 (12) (2022)
Nafise Ghalandari, R J E M Dolhain, J M W Hazes, E P van Puijenbroek, M Kapur, H J M J Crijns
Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 80 (16) (2021)
Nafise Ghalandari, R J E M Dolhain, J M W Hazes, C L E Siezen, J W van der Laan, H J M J Crijns, E P van Puijenbroek, C J van der Woude
The pre- and post-authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation. British journal of clinical pharmacology 86 (3) (2020)

Nafise Ghalandari.css-eqlu8i{font-size:small;padding-left:4px;} (N Ghalandari)